Compliance program studies should contain three arms for evaluation -- NACDS workshop.
Executive Summary
PHARMACY COMPLIANCE PROGRAM STUDIES SHOULD ENROLL THREE ARMS of patients to assess the effectiveness of such programs in promoting compliance with drug therapy, Hoscheit Consultants' Donald Hoscheit urged at the National Association of Chain Drug Stores pharmacy conference in Boston Aug. 26. Compliance program studies should examine the behaviors of "patients who opt out...another double-blind group and then those compliant patients or those who enrolled in the program," Hoscheit said.